Efficacy and Safety of Semaglutide Versus Placebo on Cardiometabolic Profile in Patients With Schizophrenia With Metabolic Syndrome
Efficacy and Safety of Semaglutide Versus Placebo on Cardiometabolic Profile in Patients With Schizophrenia With Metabolic Syndrome
Not yet recruiting · NCT07770282 · Registry updated 2026-08-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Semaglutide Versus Placebo on Cardiometabolic Profile in Patients With Schizophrenia With Metabolic Syndrome | Insulin Resistance, Nutritional and Metabolic Diseases, Schizophrenia Spectrum and Other Psychotic Disorders, glucose metabolism disease, hyperinsulinism, metabolic disease, psychiatric disorder, schizophrenia | Not yet recruiting | Phase 3 | 2026-08-18 | NCT07770282 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| All India Institute of Medical Sciences, Bhubaneswar | 18 |
| Indian Council of Medical Research | 29 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||